Abundance of BRCA1 transcripts in human cancer and lymphoblastoid cell lines carrying BRCA1 germ-line alterations

International Journal of Cancer

Volumn 73, Issue 5, 1997, Pages 715-718

  Ribieras, Stéphane ^a   Magdinier, Frédérique ^a   Leclerc, Delphine ^a   Lenoir, Gilbert ^a   Frappart, Lucien ^a   Dante, Robert ^a  

^a CENTRE DE RECHERCHE EN CANCÉROLOGIE DE LYON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DACTINOMYCIN; MESSENGER RNA; PRIMER DNA; RNA;

ARTICLE; BREAST TUMOR; CELL CULTURE; CELL LINE; CHEMISTRY; DRUG EFFECT; FEMALE; GENETIC TRANSCRIPTION; GENETICS; HALF LIFE TIME; HUMAN; METABOLISM; METHODOLOGY; POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE;

BREAST NEOPLASMS; CELL LINE, TRANSFORMED; DACTINOMYCIN; DNA PRIMERS; FEMALE; GENES, BRCA1; HALF-LIFE; HUMANS; POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0031588401     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19971127)73:5<715::AID-IJC17>3.0.CO;2-4     Document Type: Article

References (23)

1. BREAST CANCER INFORMATION CORE ON THE INTERNET. (http://www.nchgr. nih.gov/Intramural_research/Lab_transfer/Bic/).
2. CARR, M., MAY, F.E.B., LENNARD, T.W.B. and WESTLEY, B.R., Determination of estrogen responsiveness of breast cancer by competitive reverse-transcription-polymerase chain reaction. Brit. J. Cancer. 72, 1427-1434 (1995).
3. DANTE, R., RIBIERAS, S., BALDASSINI, S., MARTIN, V., BENZERARA, O., BOUTEILLE, C., BRÉMOND, A., FRAPPART, L., RIO, M.C. and LASNE, Y., Expression of an estrogen-induced breast-cancer-associated protein (pS2) in benign and malignant human ovarian cysts. Lab. Invest., 71, 188-192 (1994).
4. FRIEDMAN, L.S., OSTERMEYER, E.A., SZABO, C.I., DOWD, P., LYNCH, E.D., ROWELL, S.E. and KING, M.C., Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families. Nature (Genet.), 8, 399-404 (1994).
5. FUTREAL, P.A. and 26 OTHERS, BRCA1 mutations in primary breast and ovarian carcinomas. Science, 266, 120-122 (1994).
6. GAYTHER, S.A. and 15 OTHERS, Germline mutations of the BRCA1 gene in breast- and ovarian-cancer families provide evidence tor a genotype-phenotype correlation. Nature (Genet.), 11, 428-433 (1995).
7. GOWEN, L.C., JOHNSON, B.L., LATOUR, A.M., SULIK, K.S. and KOLLER, B.H., Brca1 deficiency results in early embryonic lethality characterized by neuro-epithelial abnormalities. Nature (Genet.), 12, 191-194 (1996).
8. GUDAS, J.M., NGUYEN, H., LI, T. and COWAN, K.H., Hormone-dependent regulation of BRCA1 in human breast-cancer cells. Cancer Res., 55, 4561-4565 (1995).
9. HAKEM, R. and 13 OTHERS, The tumor-suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse. Cell, 85, 1009-1023 (1996).
10. JELTSCH, J.M., ROBERTS, M., SCHATZ, C., GARNIER, J.M., BROWN, A.M.C. and CHAMBON, P., Structure of the human estrogen-responsive gene pS2. Nucleic Acid Res., 15, 1401-1414 (1983).
11. KAINU, T., KONONEN, J., JOHANSSON, O., OLSSON, H., BORG, A. and ISOLA, J., Detection of germline BRCA1 mutations in breast-cancer patients by quantitative messenger RNA in situ hybridization. Cancer Res., 56, 2912-2915 (1996).
12. LAGHAMI, K., BORENSZTEIN, P., AMBÜHL, P., FROISSART, M., BICHARA, M., MOE, O.W., ALPERN, R.J. and PAILLARD, M., Chronic metabolic acidosis enhances NHE-3 protein abundance and transport activity in the rat thick limb by increasing NHE-3 mRNA. J. clin. Invest., 99, 24-30 (1997).
13. MARQUIS, S.T., RAJAN, J.V., WYNSHAW-BORIS, A., XU, J., YIN, G.Y., ABEL, K.J., WEBER, B.L. and CHODOSH, L.W., The developmental pattern of Brca1 expression implies a role in differentiation of the breast and other tissues. Nature (Genet.), 11, 17-26 (1995).
14. MEJRAVER, S.D., PHAM, T.M., CADUFF, R.F., CHEN, M., POY, E.L., COONEY, K.A., WEBER, B., COLLINS, F.S., JOHNSTON, C. and FRANK, T.S., Somatic mutations in the BRCA1 gene in sporadic ovarian tumours. Nature (Genet.), 9, 439-443 (1995).
15. MIKI, Y. and 44 OTHERS, A strong candidate for the breast- and ovarian-susceptibility gene BRCA1. Science, 266, 66-71 (1994).
16. PUGET, N., TORCHARD, D., SEROVA, O.M., LYNCH, H.T., FEUNTEN, J., LENOIR, G.M. and MAZOYER, S.A., 1-kb alu-mediated germ-line deletion removing BRCA1 exon 17. Cancer Res., 57, 828-831 (1997).
17. RAMAKRISHNAN, R., FINK, D.J., JIANG, G., PRASHANT, D., GLORIOSO, J.C. and LEVINE, M., Competitive quantitative PCR analysis of herpes-simplex-type-1 DNA and latency-associated transcript RNA in latently infected cells of rat brain. J. Virol., 68, 1864-1873 (1994).
18. RAO, V.N., SHAO, N., AHMAD, M. and REDDY, S.P., Anti-sense RNA to the putative tumor-suppressor gene BRCA1 transforms mouse fibroblasts. Oncogene, 12, 523-528 (1996).
19. REMY, L., JACQUIER, M.F., DAEMI, N., DORÉ, J.F. and LISSITZKY, J.C., Comparative tumor morphogenesis of two human colon-adenocarcinoma cell clones xenografted in the immunosuppressed newborn rat. Differentiation, 54, 191-200 (1993).
20. ROSS, J., mRNA stability in mammalian cells. Microbiol. Rev., 59, 423-450 (1995).
21. SEROVA, O., MONTAGNA, M., TORCHARD, D., NAROD, S.A., TONIN, P., SYLLA, B., LYNCH, H.T., FEUNTEN, J. and LENOIR, G.M., A high incidence of BRCA1 mutations in 20 breast-ovarian-cancer families. Amer. J. hum. Genet., 58, 42-51 (1996).
22. THOMPSON, M.E., JENSEN, R.A., OBERMILLER, P.O., PAGE, D.L. and HOLT, J.T., Decreased expression of BRCA1 accelerates growth and is often present during breast cancer progression. Nature (Genet.), 9, 444-450 (1995).
23. WILSON, C.A., PAYTON, M.A., ELLIOTT, G.S., BUAAS, F.W., CAJULIS, E.E., GROSSHANS, D., RAMOS, L., REESE, D.M., SLAMON, D.J. and CALZONE, F.J., Differential subcellular localization expression and biological toxicity of BRCA1 and the splice variant BRCA1-Δ11b. Oncogene, 14, 1-14 (1997).